Bioheart Inc., of Sunrise, Fla., received a notice of allowance for nine patent claims covering the use of electrical stimulation to enhance stem cell regeneration of damaged heart muscle...Cytori said a notice of allowance had been granted for a patent covering a population of stem cells, progenitor cells and other replicating cells, which can be obtained from human adipose tissue
Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No...7,393,830, titled "Prolactin induced increase in neural stem cells numbers
7,378,098, titled "CXC Chemokine Receptor 4 Agonist Peptides," which relates to the treatment of patients in need of bone marrow or stem cell transplantation
7,282,222, which covers methods and compositions for delivering and directing stem cells to target organs in the body...That technology, licensed from the Department of Veterans Affairs, is being used to develop stem cell-enabling therapeutic products to improve the delivery and retention of adult stem cells to diseases and other target organs
BioE Inc., of St. Paul, Minn., received U.S. Patent 7,160,723, which provides protection for its cell separation compositions for isolating the company's Multi-Lineage Progenitor Cell stem cell
Stem Cell Innovations Inc., of Houston, received U.S. Patent No...7,153,684, covering human pluripotent stem cells, specifically isolated human primordial germ cell-derived pluripotent stem cells
7,115,360, titled "Isolation and Use of Solid Tumor Stem Cells," covering an approach for testing of cancer stem-cell therapeutics to inhibit human tumor growth in preclinical models
Geron Corp., of Menlo Park, Calif., was granted U.S. Patent 7,033,831, covering methods for scalable production of pancreatic islet cells from human embryonic stem cells for use in cell-based treatments for diabetes
That patent covers methods of using the reovirus ex vivo to eliminate contaminating cancer cells from autologous blood stem cell transplants...ReNeuron Group plc, of Guildford, UK, received a notice of allowance for a patent covering methods of treatment of different types of brain damage by the transplantation of conditionally immortal stem cells
6,991,897, titled "A Method of Isolating Stem Cells," describing methods of isolating adult stem cells from various sources based on the elevated intracellular enzyme, aldehyde dehydrogenase, as a stem cell marker
Stem Cell Sciences Ltd., of Edinburgh, Scotland, was granted U.S. Patent No...6,878,542, covering methods of enriching for any type of mammalian stem cell based on introduced genes, such as fluorescent markers or cell surface proteins
6,911,201, titled "Method of Producing Undifferentiated Hematopoietic Stem Cells Using a Stationary Phase Plug Flow Bioreactor...It protects the company's PluriX bioreactor, and covers the concept of creating a three-dimensional bone-like environment that supports expansion of hematopoietic stem cells from cord blood samples
Pluristem Life Systems Inc. , of Haifa, Israel, received a notice of allowance for its patent, "Method of Producing Undifferentiated Hemapoietic Stem Cells Using a Stationary Phase Plug Flow Bioreactor
Bioheart Inc., of Sunrise, Fla., received a notice of allowance for nine patent claims covering the use of electrical stimulation to enhance stem cell regeneration of damaged heart muscle...Cytori said a notice of allowance had been granted for a patent covering a population of stem cells, progenitor cells and other replicating cells, which can be obtained from human adipose tissue